Author Archives: Janet Stewart, MSc

Eloctate Improves Joint Health in Hemophilia A, Phase 3 Study Shows

Interim results from the Phase 3 ASPIRE study indicate that patients with hemophilia A showed continuous improvement in joint health for nearly three years while receiving prophylactic dosing of Bioverativ and Sobi’s Eloctate. The interim results were reported in a study titled, “Improved joint health in subjects with severe haemophilia A…